Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
about
Counteraction of the multifunctional restriction factor tetherinThe Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.Non-M variants of human immunodeficiency virus type 1.Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.Origin of the HIV-1 group O epidemic in western lowland gorillas.HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integraseNef proteins of epidemic HIV-1 group O strains antagonize human tetherin.A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.High Rate of Simian Immunodeficiency Virus (SIV) Infections in Wild Chimpanzees in Northeastern Gabon.HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV VariantsAn antiretroviral drug-naïve human immunodeficiency virus-1 infected woman with a persistent non-reactive proviral deoxyribonucleic acid polymerase chain reaction: a case report.Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon.HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.Surveys, Serologies, and Sequences Reveal History of Iatrogenic Transmission of HIV-1.A cheap and open HIV viral load technique applicable in routine analysis in a resource limited setting with a wide HIV genetic diversity.
P2860
Q28659945-D4155170-2BE4-4555-AD92-E46157ED7B84Q30377499-39CB3245-32F1-4D16-9F38-4D51432D3F1EQ30432689-242AD669-9022-4F86-8663-A99720E7BACAQ34108713-9E2EFE98-6240-404D-9931-0F2EFB352E7CQ34465404-4AE3C629-862E-4A7B-8A2C-8C272117BAE9Q34597650-F1FF0DE4-822D-48EC-8D38-EBD097159D54Q34761549-DF5A172F-8B4B-4E14-A0C3-028AAD7FF902Q35807096-43AE2B9D-BAD4-476E-91CC-1AF1FC088584Q36096423-8A4BD67D-0DBB-4DA2-BBA2-E41E7B8561AAQ36376394-0295E2DE-6DAF-45D9-8C24-766E15737B13Q36628369-0B7A1BDC-6522-42B1-A929-787BBA52FF2DQ36834771-8D830079-34B4-47D8-A8BC-2E9DA35235D3Q36946949-C77D940C-3BFC-4C62-A74F-BC664A87CAA1Q37586704-B76853B5-89B8-422E-A02D-2C4EE482CD87Q40797960-A52E9C5D-CF17-42F5-8E94-DADF348F7445Q45031263-E878EB5D-02AA-4DF7-8E38-CD35EF800F48Q46838906-8AC209BA-C777-43EE-B3EE-929291492BBD
P2860
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@en
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@nl
type
label
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@en
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@nl
prefLabel
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@en
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@nl
P2093
P50
P1476
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
@en
P2093
Agnès Depatureaux
Aurélia Vessière
François Simon
Marie Leoz
P304
P356
10.1097/QAI.0B013E3181B97EC1
P407
P577
2010-01-01T00:00:00Z